No Data
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Favourable Signals For Shoulder Innovations: Numerous Insiders Acquired Stock
Shoulder Innovations Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results and Raised Its FY2026 Sales Guidance Above Estimates.
Piper Sandler Maintains Shoulder Innovations(SI.US) With Buy Rating, Maintains Target Price $19
Goldman Sachs Maintains Shoulder Innovations(SI.US) With Buy Rating, Maintains Target Price $20
Earnings Call Summary | Shoulder Innovations(SI.US) Q1 2026 Earnings Conference